More on ZNTL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-29.7% Growth)
- Ratings (5.7 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zentalis Pharmaceuticals (NQ:ZNTL)
Delayed: 4.51 +0.18 (4.16%)
Prev. Close $4.33  
Open$4.36 
52 Wk High$ 
52 Wk Low$ 
Day High$4.65 
Day Low$4.35 
P/E N/A  
EPS$ 
Volume1,029,576 


Jul 23, 2026 07:26 AM Rodman & Renshaw Starts Zentalis Pharmaceuticals (ZNTL) at Buy
Jul 17, 2026 04:15 PM Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
Jul 17, 2026 04:25 AM Mizuho Starts Zentalis Pharmaceuticals (ZNTL) at Outperform
Jun 18, 2026 04:09 PM Form 4 Zentalis Pharmaceuticals For: Jun 16 Filed by: Johnson David Michael
Jun 18, 2026 04:09 PM Form 4 Zentalis Pharmaceuticals For: Jun 16 Filed by: Skvarka Jan
Jun 18, 2026 04:08 PM Form 4 Zentalis Pharmaceuticals For: Jun 16 Filed by: Walker Luke Nathaniel
Jun 18, 2026 04:07 PM Form 4 Zentalis Pharmaceuticals For: Jun 16 Filed by: Kariuki Enoch
Jun 18, 2026 04:06 PM Form 4 Zentalis Pharmaceuticals For: Jun 16 Filed by: Myers Scott Dunseth
Jun 18, 2026 04:03 PM Form 8-K Zentalis Pharmaceuticals For: Jun 16
Jun 1, 2026 05:00 PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with ZNTL

View All Entities